OTLK
OTLK
US69012T3059
Outlook Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
145.8M EUR
297.48M EUR
21.55M EUR
102M EUR
Enterprise Value
144.49M EUR
304.67M EUR
40.99M EUR
130.22M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.99x
--
--
--
Price to Sales
-125.31x
--
64.69x
495.86x
Price to Book
--
--
--
--
EV/Revenue
-124.19x
--
123.04x
633.03x
EV/EBITDA
-2.6x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-25.62%
-18.88%
-218.3%
-38.45%
ende